My guest on this show is Amanda Glassman, research fellow and director of CGD’s Global Health Program. I recorded this Wonkcast with her last week, just ahead of the first pledging session for the Global Alliance for Vaccines and Immunizations (GAVI).
CGD Policy Blogs
One result of President Obama’s visit to the UK last month was a statement on the UK-US Partnership for Global Development in which the U.S. President and Prime Minister David Cameron “reaffirm [their] commitment to changing the lives of 1.2 billion poor people in the world today." In the statement they promise to work together on a range of important development issues: economic growth, conflict and fragile states, aid (accountability, transparency, results), global health, girls and women, and climate change.
Earlier today, Bill Gates met with the Norwegian Prime Minister Jens Stoltenberg to talk about scaling-up immunization efforts in advance of GAVI’s June 13th pledging conference.
Our new visiting fellow Andy Sumner has drawn attention to the fact that most of the world’s poor now live in middle-income countries, not low-income countries. As it turns out, most of the world’s unvaccinated one-year olds also live in middle-income countries, specifically the lower middle-income countries. It’s actually been this way for the past decade. Although, on average, vaccination rates are higher in the LMICs than the LICs (86% vs.
As the GAVI Alliance gears up for its pledging conference in June, a CGD panel reflected on progress and lessons learned in financing GAVI since 2001 and explored implications for the next decade. Speakers had first-hand experience in the design and implementation of the major vaccine financing instruments—Alice Albright, former CFO of GAVI; Michael Kremer, co-chair of CGD’s Advance Market Commitment (AMC) Working Group; Helen Evans and David Ferreira, GAVI; and Amie Batson, Deputy Assistant Administrator for Global Health at USAID. Key takeaways from the event are directly below, and a longer summary—with embedded video clips—is below that. You can also watch a full recording of the event here.
USAID Administrator Rajiv Shah gave a speech yesterday at the National Institutes of Health, highlighting his aspirations for U.S. leadership on global health. By 2015, among other goals, he hopes that “the majority of all children have access to pentavalent, rota, pneumo and meningitis vaccines and that we have eradicated polio.”
Unlike some aspirational goals, this goal is actually feasible and affordable.
This weekend, children in Nicaragua received Advance Market Commitment (AMC)-financed pneumococcal vaccines that protect against the strains of pneumonia, meningitis and sepsis common in poor countries. Thanks in part to the AMC, the new and improved pneumo vaccines will reach the world's poorest children during the same year children in wealthy countries obtained access, and at a fraction of the price.
Last week, the U.S. Senate Health, Education, Labor, & Pensions (HELP) Committee held a hearing that had all the elements of an important event for global health.
Daddy Healthbucks: How Will the Gates Foundation Leverage the New $10 Billion for Vaccines and Immunization?
In announcing a $10 billion, decade-long commitment for vaccine development and immunization in poor countries, Bill Gates made no claims that the vaccine financing challenges are solved. Quite the contrary. He and many others have highlighted the need for other donors, industry and developing country governments to up their own ante to immunization.
Early this month the U.S. Senate passed an amendment to pending legislation that has the potential to strengthen and streamline regulations governing the clinical testing of drugs for neglected diseases in the developing world. The targeted diseases include malaria and TB, which annually kill an estimated 2.5 million people in the developing world, plus scores of diseases you may have never heard of (such as Chagas disease and leishmaniasis), but that nonetheless exact a large and lethal toll, especially on children and poor people in developing countries.